Cambridge-based Kymab is one of several rising stars on the UK biotech scene, with technology that uses transgenic mice to develop antibodies optimised for the human immune system. It has ...
Kymab has teamed up with The Scripps Research ... achieved a milestone in producing this response in genetically adapted mice. The paper, “Priming HIV-1 broadly neutralising antibody precursors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback